Medically reviewed by Susan Russell, MD Having a first-degree relative with OSA raises your chance of developing the condition.Genetics may affect OSA risk through obesity, airway structure, and where ...

For some people, this drug, Zepbound (tirzepatide), could be part of a larger arsenal of tools for treating a condition linked to various health risks. “Untreated, obstructive sleep apnea is ...

Dublin, April 06, 2023 (GLOBE NEWSWIRE) -- The "Obstructive Sleep Apnea (OSA) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.

Eli Lilly’s experimental weight-loss drug retatrutide reduced sleep apnea symptoms by over 50% in 68% of trial participants.

DelveInsight's 'Obstructive Sleep Apnea Pipeline Insight 2025' report provides comprehensive global coverage of pipeline obstructive sleep apnea therapies in various stages of clinical development, ...

Credit: Getty Images Obstructive sleep apnea may significantly increase the risk for coronary artery disease, atrial fibrillation, cerebrovascular accident, and congestive heart failure. Obstructive ...

Please provide your email address to receive an email when new articles are posted on . Adults with obstructive sleep apnea had a greater reduction in events per hour at 1 year with tirzepatide vs.

Samsung's upgraded Sleep Apnea feature reaches Samsung Galaxy Ring and Watch9 in the US, with screening limits and India ...

People living with obstructive sleep apnea are twice as likely to experience sudden death compared to people living without the condition, according to a new study. Obstructive sleep apnea (OSA) ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

Eli Lilly's retatrutide cut breathing interruptions and drove significant weight loss in sleep apnea patients, as well as ...